Newsroom
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nullam eget orci accumsan, laoreet sapien et, fermentum felis.
DermaSensor Study Results For Skin Cancer Detection Device Performance Across Skin Tones Of Over 1,000 Patients
Presented at the 2023 American Academy of Dermatology Innovation Academy, the findings demonstrate the potential for DermaSensor’s device to help detect skin cancer across a range of skin types MIAMI, August 10, 2023, Business Wire …
DermaSensor Presents Study Results on Melanoma Detection in a Medicare Population at American Dermoscopy Meeting
DermaSensor’s Device with FDA Breakthrough Designation Demonstrated 96.2% Sensitivity for Detecting Melanoma in Patients Aged 65 and Older MIAMI, July 13, 2023, Business Wire — DermaSensor Inc., a health technology company equipping primary care physicians …
DermaSensor Kicks off Skin Cancer Awareness Month by Winning “Best New Technology Solution in Dermatology”
MIAMI, May 9, 2023, EINPresswire.com — DermaSensor Inc. is pleased to announce that it is a winner in the 2023 MedTech Breakthrough Awards program for its innovative, non-invasive device that better equips primary care physicians …
DermaSensor’s Non-Invasive Skin Cancer Device Found to Halve the Number of Skin Cancers Not Referred by PCPs
Presented at the Society of Teachers of Family Medicine (STFM) 2023 annual meeting, the two FDA pivotal studies validated the performance and benefit of the hand-held, non-invasive, optical spectroscopy device in point-of-care skin lesion evaluation. …
DermaSensor Recognized as 2023 Edison Silver Award Winner with its FDA Breakthrough Device for Skin Cancer Detection
MIAMI, April 21, 2023, EINPresswire.com — DermaSensor Inc., a health technology company that has developed a non-invasive device to better equip primary care physicians (PCPs) to detect skin cancer, is proud to announce that its …
DermaSensor Unveils Study Results Demonstrating Ability to Detect Skin Cancer With Device Granted FDA Breakthrough Designation
Presented at the American Academy of Dermatology (AAD) 2023 Annual Meeting, the FDA-submitted studies mark the first successful pivotal clinical study for any skin cancer detection device for primary care physicians MIAMI, March 17, 2023, …
DermSensor Inc. Announces the Addition of Dr. Jane Grant-Kels to its Scientific Advisory Board
MIAMI, March 03, 2023, EINPresswire.com — DermaSensor Inc., a health technology company that develops non-invasive tools to better equip primary care physicians (PCPs) to detect skin cancer, today announced the appointment of Dr. Jane Grant-Kels …
DermaSensor Announces Major Hires of Chief Commercial Officer, Director of Medical Affairs, Chief Operating Officer
Company Announces Larry Anderson as Chief Commercial Officer, Dr. Vivien Nguyen as Dir. of Medical Affairs, Ryan Freiden promoted to Chief Operating Officer MIAMI, September 1, 2022, EINPresswire.com — DermaSensor Inc., a health technology company …
DermaSensor Announces Publication of Positive Results from Clinical Validation Study of Skin Cancer Detection Device
MIAMI, FLORIDA, USA, July 7, 2022 /EINPresswire.com/ — DermaSensor Inc., a health technology company designing non-invasive tools to better equip primary care physicians (PCPs) to detect skin cancer, today announces the PATIENT-SELECT study results at the American Dermoscopy …
Company Successfully Completes First Ever FDA Pivotal Study for Skin Cancer Detection Device for Primary Care
MIAMI, FLORIDA, UNITED STATES, June 15, 2022 /EINPresswire.com/ Miami-Based DermaSensor, Inc. Raises Additional $10 Million To Prepare for U.S. Launch DermaSensor Inc., a health technology company designing non-invasive tools to better equip primary care physicians (PCPs) …